Log In
BCIQ
Print this Print this
 

MTL-CEBPA (formerly MTL-501)

  Manage Alerts
Collapse Summary General Information
Company MiNA Therapeutics Ltd.
DescriptionSmall activating RNA (saRNA) targeting CEBPA gene formulated with lipid based nanoparticle
Molecular Target CCAAT enhancer binding protein alpha (CEBPA)
Mechanism of ActionGene therapy
Therapeutic ModalityNucleic acid: Linear RNA

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today